Efficacy and Safety of Vemurafenib in Acral and Mucosal Melanoma Patients with BRAF Gene Mutation

Efficacy and Safety of Vemurafenib in Acral and Mucosal Melanoma Patients with BRAF Gene Mutation

Objective To explore the efficacy and safety of Vemurafenib in acral and mucosal melanoma patients with BRAF gene mutation. Methods We retrospectively analyzed the clinical data of 24 patients diagnosed as BRAF gene-mutant acral melanoma (AM) or mucosal melanoma (MM) hospitalized in Peking Universit...

Full description

Bibliographic Details
Main Authors: WEI Xiaoting, BAI Xue, MAO Lili, CHI Zhihong, SHENG Xi'nan, CUI Chuanliang, WANG Xuan, LIAN Bin, TANG Bixia, YAN Xieqiao, LI Siming, ZHOU Li, GUO Jun, SI Lu
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2018-11-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
acral melanoma
mucosal melanoma
vemurafenib
efficacy
safety
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0250.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0250.htm

Similar Items